Wiegand, Steffen B.
Beggel, Bastian
Wranke, Anika
Aliabadi, Elmira
Jaroszewicz, Jerzy
Xu, Cheng-Jian http://orcid.org/0000-0003-1586-4672
Li, Yang
Manns, Michael P.
Lengauer, Thomas
Wedemeyer, Heiner
Kraft, Anke R. M.
Falk, Christine S.
Cornberg, Markus
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TTU 05.806)
Article History
Received: 20 March 2019
Accepted: 16 September 2019
First Online: 1 October 2019
Competing Interests
: J.J. has received compensation as a member of the scientific advisory board of Abbvie, Bristol-Myers Squib, Gilead Sciences, MSD Sharp & Dohme/Merck and Roche. He also hold lectures for Abbvie, Bristol-Myers Squib, Dia Sorin, Gilead Sciences, Grifols, MSD Sharp & Dohme/Merck, Roche, Woerwag and received lecture fees. M.P.M. has been funded by Roche, Bristol Myers Squibb, Gilead. He has received honoraria for consulting/holding lectures for Roche, Bristol Myers Squibb, Gilead, Medgenics, Enyo Pharma, Curevac. H.W. has received honoraria for consulting/speaking from BMS, Gilead, Janssen, Roche Diagnostics, Abbott, Roche. M.C.’s work has been funded by Roche Pharma. He has received compensation as a member of the scientific advisory board of Abbvie Deutschland GmbH, Bristol-Myers Squibb, Biogen Idec, Gilead Sciences, Janssen-Cilag, MSD Sharp & Dohme/Merck, Roche Diagnostics Roche Pharma. He also hold lectures for Falk Foundation e.V. and received lecture fees. S.B.W., C.F., E.A., A.R.M.K., B.B., A.W., C.J.X., Y.L. and T.L. declare no potential conflict of interest.